Resolution of shawl sign in dermatomyositis using pulsed dye laser

Debeuf, Marie-Eline Pauline Henriette; Onna, Marloes van; Verstraeten, Valerie L. R. M.

doi:10.1016/j.jdcr.2021.07.032

Cited by 2 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are often resistant to medical therapy. [ 22 ] However, there are cases reporting the successful use of PDL in the treatment of poikiloderma[ 23 24 ] and Gottron’s papules[ 25 ] where a 70% improvement was noted, with no recurrence after three years. Fractional ablative CO 2 laser has also successfully been used in the treatment of ulcerating calcifications in dermatomyositis by causing liquefaction.…”

Section: Discussionmentioning

confidence: 99%

The role of lasers in connective tissue and inflammatory dermatoses: A 10-year retrospective review of 60 patients in a UK tertiary laser clinic

Madan,

Asfour,

Ismail

2023

Indian Dermatol Online J

View full text Add to dashboard Cite

Introduction: The role of lasers in the treatment of standard therapy-resistant inflammatory dermatoses and connective tissue disorders has been controversial and evidence supporting the role of lasers in this setting is scarce. Objective: To assess the efficacy of lasers in the management of inflammatory dermatoses and connective tissue disorders (CTD). Materials and Methods: A retrospective case review of all inflammatory dermatoses/connective tissue diseases treated in a tertiary laser clinic between March 2010 and 2020 was undertaken. Results: A total of 60 cases (48 = female) were included and the average age was 51 years (range 21 to 74). The following conditions were treated: scleroderma n = 22 (37%), granuloma faciale n = 10 (17%), sarcoidosis n = 8 (13%), discoid lupus erythematosus n = 7 (12%), and systemic lupus erythematosus n = 2 (3%). Other diagnoses included necrobiosis lipoidica, pyoderma vegetans, hypertrophic lichen planus, and dermatomyositis. The most common type of laser used was pulsed dye laser (PDL) in n = 41 (68%) cases. Eight (13%) patients received treatment with the carbon dioxide (CO 2 ) laser. The most common site treated was the face. A good response with a marked reduction of signs was seen in 62% of patients while 10% of the patients did not respond to laser treatment. Self-limiting complications included purpura and hyperpigmentation. Limitations: Lack of objective assessment and outcome measures. Conclusions: This is the largest cohort of patients to have undergone laser treatment for inflammatory dermatoses/connective tissue disease. Based on this retrospective review, we conclude that lasers can be a useful adjunct in the management of otherwise difficult-to-treat selected inflammatory and connective tissue diseases.

show abstract

Section: Discussionmentioning

confidence: 99%